MELAS and l-arginine therapy: Pathophysiology of stroke-like episodes

Annals of the New York Academy of Sciences

Volumn 1201, Issue , 2010, Pages 104-110

  Koga, Yasutoshi ^a   Povalko, Nataliya ^a   Nishioka, Junko ^a   Katayama, Koujyu ^a   Kakimoto, Noriko ^a   Matsuishi, Toyojiro ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

endothelial function; l arginine; MELAS; mitochondrial angiopathy; mitochondrial cytopathy

Indexed keywords

ARGINASE; ARGININE; ARGININE DECARBOXYLASE; ARGININOSUCCINATE LYASE; ARGININOSUCCINATE SYNTHASE; CARBAMOYL PHOSPHATE SYNTHASE; CYTOCHROME C OXIDASE; GLYCINE AMINOTRANSFERASE; GUANIDINOACETATE METHYLTRANSFERASE; NITRIC OXIDE SYNTHASE; GLUCOSE; OXYGEN;

ACIDURIA; AMINO ACID METABOLISM; AMINO ACID SYNTHESIS; ASTHMA; CELL DAMAGE; CENTRAL PONTINE MYELINOLYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG MECHANISM; ENDOTHELIAL DYSFUNCTION; HUMAN; HYPONATREMIA; HYPOTENSION; MELAS SYNDROME; MITOCHONDRIAL ANGIOPATHY; NECROTIZING ENTEROCOLITIS; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN INTOLERANCE; PULMONARY HYPERTENSION; RESPIRATORY CHAIN; SIDE EFFECT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STROKE; TREATMENT RESPONSE; VASODILATATION; BIOLOGICAL MODEL; BRAIN; CHEMISTRY; ENDOTHELIUM; HOMEOSTASIS; METABOLISM; METHODOLOGY; MITOCHONDRION; MUSCLE; PATHOLOGY; REVIEW;

ARGININE; BRAIN; ENDOTHELIUM; GLUCOSE; HOMEOSTASIS; HUMANS; MAGNETIC RESONANCE IMAGING; MELAS SYNDROME; MITOCHONDRIA; MITOCHONDRIAL DISEASES; MODELS, BIOLOGICAL; MUSCLES; OXYGEN; STROKE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 77955288655     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2010.05624.x     Document Type: Conference Paper

References (39)

1. Pavlakis, S.G., P.C. Phillips, S. DiMauro, et al. 1984. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann. Neurol. 16: 481-488.
2. Iizuka, T. & F. Sakai. 2010. Pathophysiology of stroke-like episodes in MELAS: neuron-astrocyte uncoupling in neuronal hyperexcitability. Future Neurol. 5: 61-83.
3. Goto, Y.I., I. Nonaka & S. Horai. 1990. A mutation in the tRNA (Leu(UUR)) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 348: 651-653.
4. Goto, Y.I., S. Horai, T. Matsuoka, et al. 1992. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS): a correlative study of the clinical features and mitochondrial DNA mutation. Neurology 42: 545-550.
5. Ohama, E., S. Ohara, F. Ikuta, K. Tanaka, et al. 1987. Mitochondrial angiopathy in cerebral blood vessels of mitochondrial encephalomyopathy. Acta Neuropathol. 74: 226-233.
6. Kishi, M., Y. Yamamura, T. Kurihara, et al. 1988. An autopsy case of mitochondrial encephalomyopathy: biochemical and electron microscopic studies of the brain. J. Neurol. Sci. 86: 31-40.
7. Hasegawa, H., T. Matsuoka, Y. Goto & I. Nonaka. 1991. Strongly succinate dehydrogenase-reactive blood vessels in muscles from patients with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes. Ann. Neurol. 29: 601-605.
8. Koga, Y., M. Ishibashi, I. Ueki, S. Yatsuga, et al. 2002. Effects of L-arginine on the acute phase of strokes in three patients with MELAS. Neurology 58: 827-828.
9. Koga, Y., Y. Akita, J. Nishioka, et al. 2005. L-arginine improves the symptoms of stroke-like episodes in MELAS. Neurology 64: 710-712.
10. Finsterer, J. 2007. Genetic, pathogenic, and phenotypic implications of the mitochondrial A3243 G tRNALeu(UUR) mutation. Acta Neurol. Scand. 116: 1-14.
11. Chomyn, A., A.Martinuzzi,M. Yoneda, et al. 1992. MELAS mutation in mtDNA binding site for transcription termination factor causes defects in protein synthesis and in respiration but no change in levels of upstream and downstream mature transcripts.Proc.Natl.Acad. Sci.USA89: 4221-4225.
12. Yasukawa, T., T. Suzuki, T. Suzuki, et al. 2000. Modification defect at anticodon wobble nucleotide of mitochondrial tRNAs( Leu)(UUR) with pathogenic mutations of mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. J. Biol. Chem. 275: 4251-4257.
13. King,M.P.,Y.Koga,M.Davidson & E.A. Schon. 1992. Defects in mitochondrial protein synthesis and respiratory chain activity segregate with the tRNA(Leu(UUR)) mutation associated with mitochondrialmyopathy, encephalopathy, lactic acidosis, and strokelike episodes.Mol.Cell.Biol. 12: 480-490.
14. Koga, Y., M. Yoshino & H. Kato. 1998. MELAS exhibits dominant negative effects on mitochondrial RNA processing. Ann. Neurol. 43: 835.
15. Koga, Y., A. Koga, Y. Akita, R. Fukiyama, et al. 2003. Increased mitochondrial processing intermediates associated with threet RNALeu(UUR) gene mutations. Neuromuscul. Disord. 13: 259-262.
16. Koga, Y., I. Nonaka, M. Kobayashi, et al. 1988. Findings in muscle in complex I (NADH Coenzyme Q reductase) deficiency. Ann. Neurol. 24: 749-756.
17. Jahangier Tafewchi, R.S., P.J. Svenson, G.M. Janssen, et al. 2005. Distinct nuclear gene expression profiles in the cells with mtDNA depletion and homoplasmic A3243G mutation. Mutat. Res. 578: 43-52.
18. Sakuta, R. & I. Nonaka. 1989. Vascular involvement in mitochondrial myopathy. Ann. Neurol. 25: 594-601.
19. Naini, A., P. Kaufmann, S. Shanske, et al. 2005. Hypocitrullinemia in patients with MELAS: an insight into the "MELAS paradox". J. Neurol. Sci. 229-230: 187-193.
20. Tanahashi, C., A.Nakayama,M. Yoshida, et al. 2000. MELAS with the mitochondrial DNA 3243 point mutation: a neuropathological study. Acta Neuropathol. 99: 31-38.
21. Iizuka, T., F. Sakai, T. Ide, et al. 2007. Regional cerebral blood flow and cerebrovascular reactivity during chronic stage of stroke-like episodes in MELAS-implication of neurovascular cellular mechanism. J. Neurol. Sci. 257: 126-138.
22. Noguchi,A., Y. Shoji, M. Matsumori, et al. 2005. Stroke-like episode involving a cerebral artery in a patient withMELAS. Pediatr. Neurol. 33: 70-71.
23. Iizuka, T., Y. Goto, S. Miyakawa, et al. 2009. Progressive carotid artery stenosis with a novelt RNA phenylalanine mitochondrial DNA mutation. J. Neurol. Sci. 278: 35-40.
24. Kubota, M., Y. Sakakihara, M. Mori, et al. 2004. Beneficial effect of L-arginine for stroke-like episode inMELAS. Brain Dev. 26: 481-483.
25. Wilichowski, E., P.J. Pouwels, J. Frahm & F. Hanefeld. 1999. Quantitative proton magnetic resonance spectroscopy of cerebral metabolic disturbances in patients with MELAS. Neuropediatrics 30: 256-263.
26. Kaufmann, P.,D.C. Shungu,M.C. Sano, et al. 2004. Cerebral lactic acidosis correlates with neurological impairment in MELAS. Neurology 62: 1297-1302.
27. Koga, Y., Y. Akita, N. Junko, et al. 2006. Endothelial dysfunction in MELAS was improved by L-arginine supplementation. Neurology 66: 1766-1769.
28. Nishioka, J., Y. Akita, S. Yatsuga, et al. 2008. Inappropriate intracranial hemodynamics in the natural course ofMELAS. Brain Dev. 30: 100-105.
29. Ikawa,M.,H.Okazawa,K.Arakawa, et al. 2009. PETimaging of redox and energy states in stroke-like episodes of MELAS. Mitochondrion 9: 144-148.
30. Nariai,T., K. Ohno,Y.Ohta, et al. 2001. Discordance between cerebral oxygen and glucose metabolism, and hemodynamics in a mitochondrial encephalomyopathy, lactic acidosis, and strokelike episode patient. J.Neuroimaging 11: 325-329.
31. Molńar, M.J., A. Valikovics, S. Molńar, et al. 2000. Cerebral blood flow and glucose metabolism in mitochondrial disorders. Neurology 55: 544-548.
32. Gerriets,T., E. Stolz,M.Walberer, et al. 2004.Middle cerebral artery occlusion during MR-imaging: investigation of the hyperacute phase of stroke using a new in-bore occlusion model in rats. Brain Res. Protoc. 12: 137-143.
33. Ohshita, T., M. Oka, Y. Imon, et al. 2000. Serial diffusionweighted imaging in MELAS. Neuroradiology 42: 651-656.
34. Ito,H., K.Mori,M.Harada, et al. 2008. Serial brain imaging analysis of stroke-like episodes in MELAS. Brain Dev. 30: 483-488.
35. Wang, X.Y., K. Noguchi, S. Takashima, et al. 2003. Serial diffusion-weighted imaging in a patient with MELAS and presumed cytotoxic oedema. Neuroradiology 45: 640-643.
36. Stoquart-Elsankari, S., P. Lehmann,B. Ṕerin, et al. 2008.MRI and diffusion-weighted imaging followup of a stroke-like event in a patient with MELAS. J. Neurol. 255: 1593-1595.
37. WangD, X.L., A.S. Sim, R.F. Badenhop, et al. 1996. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat. Med. 2: 41-45.
38. Moutaouakil, F., H. El Otmani, H. Fadel, et al. 2009. Larginine efficiency in MELAS syndrome. A case report. Rev. Neurol. (Paris) 165: 482-485. (in French)
39. Coman,D., J. Yaplito-Lee & A. Boneh. 2008.Newindications and controversies in arginine therapy. Clin. Nutr. 27: 489-496.